Replies to post #204161 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

But Dr. Alkon said look at the data, yet was absent at NTRP's last share holder meeting?


Sorry NTRP is only listed on NASDAQ because of a 1:32 reverse split in 2017.


NTRP = 1 x Placebo controlled CNS trial


AVXL = 3 x Placebo controlled CNS trials

[XenaLives]

"High" and "Low" are realtive.

His title says "High"

I am responsible for creating and overseeing Eisai's global AD/dementia medical strategies. I am also overseeing investigator-initiated trials, Phase IIIb/IV projects, and Eisai's continued medical education and medical information programs.

https://www.researchgate.net/profile/Harald_Hampel

Does anyone know of any Eisai trials that fit that description?

Curious...

This is the way Eisai announced Hampel's appointment.. do the PR all of their "low level" appointments????

Eisai Inc. Deepens Its Commitment to Alzheimer's Disease with Key Executive Appointments
Dr. Harald Hampel hired as Vice President, Global Medical Affairs, Alzheimer's Disease;

Dr. Michael Irizarry named Vice President, Clinical Research, Alzheimer's Disease

https://www.prnewswire.com/news-releases/eisai-inc-deepens-its-commitment-to-alzheimers-disease-with-key-executive-appointments-300843144.html